“Analysis of the degree of fibrosis in patients with steatotic liver disease associated with metabolic dysfunction (MASLD) using FibroScan®”, Acervo Saúde, vol. 26, no. 1, p. e22602, Jan. 2026, doi: 10.25248/reas.e22602.2026.